| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |